Two liquid biopsy panels were launched by Qiagen for use in assessing circulating tumor cells isolated from blood samples. The AdnaTest LungCancer kit determines CTCs involved in cancer growth and in a cancer therapy resistance marker called epithelial-mesenchymal transition, while the AdnaTest ProstateCancerPanel kit evaluates resistance to drugs for advanced prostate cancer as it spots the androgen receptor splice variant 7 in CTCs of prostate tumor origin.
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.